Rationale and design of a randomised clinical trial comparing vascular closure device and manual compression to achieve haemostasis after diagnostic coronary angiography: The Instrumental Sealing of ARterial puncture site - CLOSURE device versus manual compression (ISAR-CLOSURE) trial

EuroIntervention

Volumn 10, Issue 2, 2014, Pages 198-203

  Xhepa, Erion ^a   Byrne, Robert A ^a   Schulz, Stefanie ^a   Helde, Sandra ^a   Gewalt, Senta ^a   Cassese, Salvatore ^a   Linhardt, Maryam ^a   Ibrahim, Tareq ^b   Mehilli, Julinda ^c,e   Hoppe, Katharina ^d   Grupp, Katharina ^a   Kufner, Sebastian ^a   Böttiger, Corinna ^a   Hoppmann, Petra ^a   Burgdorf, Christof ^f   Fusaro, Massimiliano ^a   Ott, Ilka ^a   Schneider, Simon ^b   Hengstenberg, Christian ^a   Schunkert, Heribert ^a,e   Laugwitz, Karl Ludwig ^b,e   Kastrati, Adnan ^a,e   more..

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d Abteilung Hämatologie und Onkologie   (Germany)

^e DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^f NONE

Author keywords

Coronary angiography; Femoral access; Randomised clinical trial; Trial design; Vascular closure device

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; APPLICATION SITE BLEEDING; ARTERIOVENOUS FISTULA; ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE EFFECTIVENESS; COMPRESSION THERAPY; CONTROLLED STUDY; DEVICE SAFETY; FALSE ANEURYSM; FEMORAL ARTERY; HEMATOMA; HOMEOSTASIS; HUMAN; INCIDENCE; INFORMED CONSENT; MAJOR CLINICAL STUDY; MEDICAL ETHICS; RANDOMIZED CONTROLLED TRIAL; STUDY DESIGN; TREATMENT OUTCOME; VASCULAR ACCESS; VASCULAR CLOSURE DEVICE; BLOOD; CENTRAL VENOUS CATHETER; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; EQUIPMENT DESIGN; GERMANY; HEMORRHAGE; HEMOSTASIS; METHODOLOGY; MULTICENTER STUDY; PRESSURE; PROSPECTIVE STUDY; PUNCTURE; TIME;

CLINICAL PROTOCOLS; CORONARY ANGIOGRAPHY; EQUIPMENT DESIGN; FEMORAL ARTERY; GERMANY; HEMORRHAGE; HEMOSTASIS; HEMOSTATIC TECHNIQUES; HUMANS; PRESSURE; PROSPECTIVE STUDIES; PUNCTURES; RESEARCH DESIGN; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES;

EID: 84905501935     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV10I2A33     Document Type: Article

References (17)

1. Holmes DR Jr, Williams DO. Catheter-based treatment of coronary artery disease: past, present, and future. Circ Cardiovasc Interv. 2008;1:60-73.
2. Monagan D. Journey into the heart. Gotham Books. 2007; Penguin USA.
3. Byrne RA, Cassese S, Linhardt M, Kastrati A. Vascular access and closure in coronary angiography and percutaneous intervention. Nat Rev Cardiol. 2013;10:27-40.
4. Langwieser N. Safety and efficacy of manual compression repair and ultrasound-guided thrombin injection for the management of iatrogenic femoral artery pseudoaneurysm using a dedicated treatment algorithm based on the aneurysm morphology: experience in over 29000 consecutive patients undergoing percutaneous angiography. Circ Cardiovasc. Interv. 2014;7:207-15.
5. Dauerman HL, Applegate RJ, Cohen DJ. Vascular closure devices: the second decade. J Am Coll Cardiol. 2007;50:1617-26. (Pubitemid 47562669)
6. Turi ZG. An evidence-based approach to femoral arterial access and closure. Rev Cardiovasc Med. 2008;9:7-18.
7. Dangas G, Mehran R, Kokolis S, Feldman D, Satler LF, Pichard AD, Kent KM, Lansky AJ, Stone GW, Leon MB. Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. J Am Coll Cardiol. 2001;38:638-41. (Pubitemid 32835728)
8. Tavris DR, Dey S, Albrecht-Gallauresi B, Brindis RG, Shaw R, Weintraub W, Mitchel K. Risk of local adverse events following cardiac catheterization by hemostasis device use phase II. J Invasive Cardiol. 2005;17:644-50.
9. Tavris DR, Gallauresi BA, Lin B, Rich SE, Shaw RE, Weintraub WS, Brindis RG, Hewitt K. Risk of local adverse events following cardiac catheterization by hemostasis device use and gender. J Invasive Cardiol. 2004;16:459-64. (Pubitemid 39244890)
10. Koreny M, Riedmuller E, Nikfardjam M, Siostrzonek P, Mullner M. Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis. JAMA. 2004;291:350-7. (Pubitemid 38101608)
11. Nikolsky E, Mehran R, Halkin A, Aymong ED, Mintz GS, Lasic Z, Negoita M, Fahy M, Krieger S, Moussa I, Moses JW, Stone GW, Leon MB, Pocock SJ, Dangas G. Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis. J Am Coll Cardiol. 2004;44:1200-9. (Pubitemid 39208874)
12. Biancari F, D'Andrea V, Di Marco C, Savino G, Tiozzo V, Catania A. Meta-analysis of randomized trials on the efficacy of vascular closure devices after diagnostic angiography and angioplasty. Am Heart J. 2010;159:518-31.
13. Holm N, Sindberg B, Schou M, Maeng, M, Kaltoft A, Bøttcher M, Krusell L, Hjort J, Thuesen L, Terkelsen C, Christiansen E, Bøtker HE, Kristensen S, Lassen J. Randomised comparison of manual compression and FemoSeal vascular closure device for closure after femoral artery access coronary angiography. EuroIntervention. 2014;183-90.
14. Kambara AM, Bastos Metzger P, Ribamar Costa J Jr, Moreira SM, Penner A, Sousa A, Sousa JE, Grube E, Abizaid A. First-in-man assessment of the InSeal VCD, a novel closure device for large puncture accesses. EuroIntervention. 2013 Dec 19. [Epub ahead of print].
15. Bertrand O, Meerkin D, De Palma R. Vascular access. In: Eeckhout E, Serruys P, Wijns W, Vahanian A, Van Sambeek M, De Palma R, eds. Percutaneous Interventional Cardiovascular Medicine: The PCR-EAPCI Textbook. Europa Publishing; 2012: pages 55-76.
16. Lincoff AM, Bittl JA, Harrington RA, Feit F, Kleiman NS, Jackman JD, Sarembock IJ, Cohen DJ, Spriggs D, Ebrahimi R, Keren G, Carr J, Cohen EA, Betriu A, Desmet W, Kereiakes DJ, Rutsch W, Wilcox RG, de Feyter PJ, Vahanian A, Topol EJ; REPLACE-2 Investigators. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA. 2003;289:853-63. (Pubitemid 37430344)
17. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310:2191-4.